Sep 10 2009
MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life sciences markets, today reported financial results for the three-month period ended July 31, 2009. MDS reported total revenue of $199 million, a net loss of $62 million and a loss per share of $0.51 for the third quarter of 2009, compared with $252 million in total revenue, a net loss of $10 million and a loss per share of $0.08 for the same period last year. Current quarter results include non-cash write-downs for goodwill and fixed assets of $37 million and $7 million, of which $12 million was reported in discontinued operations. From continuing operations, MDS reported a net loss of $48 million and a loss per share of $0.40, versus a net loss of $5 million and a loss per share of $0.04 in 2008.